APOA1 binding protein promotes lymphatic cell fate and lymphangiogenesis by relieving caveolae-mediated inhibition of VEGFR3 signaling

Jun‐Dae Kim(Houston Methodist), Longhou Fang(Houston Methodist), John P. Cooke(Houston Methodist), Nhat-Tu Le(Houston Methodist), Dániel Kiss(Houston Methodist), Jonathan W. Astin(University of Auckland), Weiqing Chen(Houston Methodist), Stanley G. Rockson(Stanford University), Pengchun Yu(Oklahoma Medical Research Foundation), Surbhi Chaudhary(Institute of Microbial Technology), Philip S. Crosier(University of Auckland), Henry J. Pownall(Cornell University), Guangyu Wang(Tongji University), Hugo J. Bellen(Baylor College of Medicine)
Nature Communications
October 21, 2025
Cited by 3


Related Papers